SHAUN MCGOWAN: Open Payments
NPI 1487305173 · ROSEBURG, OR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$170 in 9 payments from 6 companies in 2025. Trend: 2023 $223 · 2024 $291 · 2025 $170
Food & beverage: $170
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 2 | $39 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $38 |
| Janssen Biotech, Inc. | 2 | $38 |
| Braintree Laboratories, Inc. | 1 | $21 |
| Gilead Sciences, Inc. | 1 | $18 |
| Madrigal Pharmaceuticals | 1 | $17 |
Products named: MAVYRET, XIFAXAN, TREMFYA, SUTAB, REZDIFFRA.
Industry payments across OR — which companies pay providers there.
